Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
about
Translational Bioinformatics: Past, Present, and FutureLarge-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug RepurposingA survey of current trends in computational drug repositioningRepositioning approved drugs for the treatment of problematic cancers using a screening approach.Repurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentRepurposing the antihelmintic mebendazole as a hedgehog inhibitor.In vitro screening for drug repositioning.Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model.Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical modelToward precision medicine in glioblastoma: the promise and the challenges.The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro.Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanomaRepurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentDrug Repurposing for the Treatment of Acute Myeloid Leukemia.Targeting acute myeloid leukemia by drug-induced c-MYB degradation.Predicting Molecular Targets for Small-Molecule Drugs with a Ligand-Based Interaction Fingerprint Approach.
P2860
Q26766146-19545B71-AEBB-49E3-BB1F-1B4B0AEA9C40Q28554586-0F3E34A6-1D21-4D42-9DDB-A1DAF3225559Q28602324-4497657E-5207-4746-849F-BEFD01CEAAD8Q29248487-095EFA6D-98EA-486A-9BF8-4257B77FA858Q33893928-B2D5A400-105F-4FA4-B0FF-CC278E2943C3Q34978358-E7D57F95-D3D8-4964-ABB6-0ED0FB30C35DQ35531225-E8A7054F-74F8-479A-9CF8-CBDCCE2BB713Q35788820-345DC59E-E9FB-4308-BE56-E8DD484F7BD0Q35920872-0C84F048-9245-4709-9CB6-A07EDEDDCD3CQ37706533-EA5B9A8B-FF8C-476D-80A3-58CBE6C4E398Q37708833-955B5286-F973-4B2C-9A06-3514AF44AC58Q38454659-62414412-61C1-43E3-B372-A4215030A509Q38704818-9FD904F5-F8E0-4AB9-BF49-D8FED30D6560Q38806553-687FD55B-C666-44B3-8625-C6ABB330401BQ38913917-040EA45F-B2C5-4FA3-98D2-E26FB785CB9DQ38981033-1ED51603-B435-4F06-AD74-3F52A8BCDE67Q41668110-CB9F3C7C-1D3E-4007-9751-136F3771F8B0Q47094576-C1CE9FFC-DA44-4459-9CC7-9C4B5D4F2F49Q47580446-AF518845-B3B6-403E-ACAE-92CB723408A0Q54256137-CAE285B4-A4F6-4638-901F-AE178B0BBE0B
P2860
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@ast
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@en
type
label
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@ast
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@en
prefLabel
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@ast
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@en
P2860
P1476
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
@en
P2093
Bengt Agerup
Mårten Fryknäs
P2860
P2888
P304
P356
10.1007/S00432-013-1539-5
P577
2013-10-18T00:00:00Z